In Novo’s Own Words: Degradation of Amylin Analogs Such as Cagrilintide (and How to Test For It)
“A hallmark of the pancreatic hormone amylin is its high propensity toward the formation of amyloid fibrils, which makes it a challenging drug design effort.”
So begins Novo Nordisk’s excellent...
glp1forum.com uses cookies and other similar functionality to help us personalize content, tailor your experience and to keep you logged in if you are a registered member.
By continuing to use this site, you are consenting to our use of cookies.